RNA Outsourcing Solutions

  1. Services Designed To Take You From Molecule To Market 6/12/2025

    Accelerate your biopharma journey with a comprehensive service portfolio designed to speed development, reduce costs, and minimize risk from molecule to market.

  2. Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

  3. Cell Therapy Product Characterization Services

    Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.

  4. Regulatory Strategy And Submission Support 12/2/2025

    This Regulatory Operations Team enables biotech and pharmaceutical companies to focus on innovation while ensuring a smooth, compliant path to market entry.

  5. Our Spokane Foreign Trade Zone (FTZ) 12/10/2025

    Foreign Trade Zones help businesses cut costs and improve efficiency by deferring or eliminating tariffs, streamlining imports, and enabling faster market access while maintaining flexibility for global distribution.

  6. Toxicology Support: Regulatory Strategy And Submission Support 12/2/2025

    Eliminate delays and ensure seamless regulatory alignment with an experienced toxicology services team.

  7. Real World Data 6/27/2023

    Accelerate patient recruitment and drug development with real world data (RWD).

  8. GMP mRNA And LNP-mRNA Manufacturing 5/13/2024

    Easily scale your GMP mRNA projects

  9. Innovative Formulations And Higher Drug Loads Across The Life-Cycle 11/20/2025

    Advanced particle engineering enhances the performance and life-cycle of therapeutics. Superior bioavailability, higher drug load, and improved stability are enabled for small and large molecules.

  10. Plasmid DNA Production 6/23/2022

    Integrated manufacturing supporting cell and gene therapies.

    The critical genetic foundation for advanced therapies

    Plasmid DNA is a critical raw material for advanced therapies and mRNA synthesis, supporting their transfection to enable rapid advancement of the therapeutic product. Center for Breakthrough Medicines (CBM) offers capacity dedicated to the development and manufacture of high quality plasmid DNA and other nucleic acids.